Physical Therapists in Toledo, IA Accepting Medicare
6 Physical Therapists found. Showing 1 - 6
 Tani Jo Lane, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1307 S Broadway St, Toledo, IA 52342 Phone: 641-484-5253 Fax: 641-484-5312 |
Shellina Marie Herink Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1307 S Broadway St, Toledo, IA 52342 Phone: 641-484-5253 Fax: 641-484-5312 |
Ms. Jean Lorie Nollen, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1307 S Broadway St, Toledo Rehab Center, Toledo, IA 52342 Phone: 641-484-5253 Fax: 641-484-5312 |
Danielle Renee Friedlein, PT, ATC Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1307 S Broadway St, Toledo, IA 52342 Phone: 641-484-5253 |
Mrs. Adelheid Christine Ernst, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1307 S Broadway St, Toledo, IA 52342 Phone: 641-484-5253 Fax: 641-484-5312 |
 Benjamin Jon Sterling Wagar, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1307 S Broadway St, Toledo, IA 52342 Phone: 641-484-5253 Fax: 641-484-5312 |
News Archive
Study investigates airborne and fomite transmission of SARS-CoV-2 in Syrian hamsters
National Institutes of Health scientists studying SARS-CoV-2, the virus that causes COVID-19, have defined in Syrian hamsters how different routes of virus exposure are linked to disease severity.
Financial boost to malaria fight would result in beneficial gains
"[A] surge in money for insecticide-treated nets and other interventions" to fight malaria over the past decade has reduced the malaria-related death rate by 26 percent since 2000, and a "new push" to fight the disease, which killed 655,000 people in 2010, would have beneficial results, according to a report set to be released by Ray Chambers, the U.N. special envoy for malaria, an Economist editorial notes.
Study to investigate use of OCT in collaboration with Melanoma Institute of Australia
Michelson Diagnostics, the UK based medical device company focused on multi-beam Optical Coherence Tomography ('OCT') technology, has commenced a clinical study to investigate the use of OCT to diagnose basal cell carcinoma in collaboration with the Melanoma Institute of Australia using Michelson's Diagnostics VivoSight system.
Results reported for clinical trial for the treatment of depression using external trigeminal nerve stimulation
Earlier today, at the American Psychiatric Association Annual Meeting in Philadelphia, Dr. Ian Cook, Principal Investigator and Professor of Psychiatry at UCLA, and a Senior Medical Advisor to NeuroSigma, Inc., presented the results of a Phase Ib open-label clinical trial that studied the effects of eTNS™ on depressive symptoms in Major Depressive Disorder (MDD) as an adjunct to pharmacotherapy. Results from the 17-question Hamilton Depression Rating Scale (HDRS-17), a clinician-rated scale, showed a 50.0% reduction in depression and the Beck Depression Inventory (BDI), a self-reported scale, showed a 58.0% reduction in scores. Both scales achieved statistical significance. In the trial, subjects placed stimulating eTNS™ electrodes on their foreheads for 8 hours each night and their depression was measured every two weeks using recognized standard tests. eTNS was well tolerated and no serious adverse events occurred during the 8-week treatment period.
Little-used measure of good cholesterol can predict heart attack and stroke risk
For decades, high-density lipoprotein (HDL) cholesterol has been dubbed "good cholesterol" because of its role in moving fats and other cholesterol molecules out of artery walls.
› Verified 6 days ago